(RTTNews) - Totus Medicines, Developer of chemical biology technologies, Tuesday announced the appointment of Simon Harnest as Chief Financial Officer. Simon with over 15 years in private capital ...

today announced the appointment of Simon Harnest, MSc, BSc, as Chief Financial Officer. This key addition comes at a pivotal moment for Totus as the company prepares to advance its clinical-stage ...

(MENAFN- GlobeNewsWire - Nasdaq) Appoints Simon Harnest as Chief financial Officer to advance capital markets and corporate development strategy supporting TOS-358, the Company's lead covalent ...

Appoints Simon Harnest as Chief Financial Officer to advance capital markets and corporate development strategy supporting TOS-358, the Company's lead covalent PI3Kα inhibitor, and additional programs ...

Appoints Simon Harnest as Chief Financial Officer to advance capital markets and corporate development strategy supporting TOS-358, the Company’s lead covalent PI3Kα inhibitor, and additional ...

Welcome to today's segment from our harness racing analyst. Providing you with free expert tips and selections for harness ...